Renal Impairment Study for Oral EC5026

NCT07694544 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: EC5026 oral tablet

Sponsor

EicOsis Human Health Inc.